HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Inada, M. Articles by Weiss, J. Search for Related Content PubMed PubMed Citation Articles by Inada, M. Articles by Weiss, J. Social Bookmarking                      What's this?

J. Biol. Chem., Vol. 269, Issue 42, 26338-26343, 10, 1994

Determinants of the inhibitory action of purified 14-kDa phospholipases A2 on cell-free prothrombinase complex

M Inada, RM Crowl, AC Bekkers, H Verheij and J Weiss
Department of Microbiology, New York University School of Medicine, New York 10016.

It has been suggested (Kini, R. R., and Evans, H. J. (1987) J. Biol. Chem. 262, 14402-14407) that the anticoagulant activity of members of the 14-kDa phospholipase A2 (PLA2) family depends on the presence of basic residues within a variable surface region (residues 54-77) distinct from both the conserved catalytic machinery and surface sites mediating the antibacterial action of these enzymes (see Weiss, J., Inada, M., Elsbach, P., and Crowl, R. M. (1994) J. Biol. Chem. 269, 26331-26337). To further define the determinants of the anticoagulant activity of PLA2, we have analyzed the inhibitory effects of purified native and recombinant PLA2 on cell-free prothrombinase. Both native and recombinant wild-type pig pancreas (net charge -1) and human "secretory" PLA2 (net charge +15) produced similar dose-dependent inhibition of prothrombinase activity that was significantly less potent than a toxic PLA2 purified from snake venom. Site-specific mutations that either increased or decreased PLA2 activity toward bactericidal/permeability-increasing protein-treated Escherichia coli by up to 50-fold had no effect on antiprothrombinase activity. In contrast, substitution of Arg for Asp-59/Gly for Ser-60 in the pig PLA2 increased antiprothrombinase activity by 5-10-fold without affecting catalytic activity toward a range of phospholipid substrates or antibacterial activity. Comparison of antiprothrombinase activity of catalytically active and inactive forms of the PLA2 and under a range of phospholipid conditions revealed that the potent antiprothrombinase activity of native toxic venom PLA2 and of the D59R.S60G mutant pancreatic PLA2 reflect combined catalytic and noncatalytic actions, the latter apparently dependent on basic residues at discrete surface sites in the enzyme.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				H. W.M Niessen, P. A.J Krijnen, C. A Visser, C. J.L.M Meijer, and C Erik Hack Type II secretory phospholipase A2 in cardiovascular disease: a mediator in atherosclerosis and ischemic damage to cardiomyocytes? Cardiovasc Res, October 15, 2003; 60(1): 68 - 77. [Abstract] [Full Text] [PDF]

				T. M. Hackeng, J. H. Griffin, and P. E. Dawson Protein synthesis by native chemical ligation: Expanded scope by using straightforward methodology PNAS, August 31, 1999; 96(18): 10068 - 10073. [Abstract] [Full Text] [PDF]

				C. M. Mounier, T. M. Hackeng, F. Schaeffer, G. Faure, C. Bon, and J. H. Griffin Inhibition of Prothrombinase by Human Secretory Phospholipase A2 Involves Binding to Factor Xa J. Biol. Chem., September 11, 1998; 273(37): 23764 - 23772. [Abstract] [Full Text] [PDF]

				T. M. Hackeng, C. M. Mounier, C. Bon, P. E. Dawson, J. H. Griffin, and S. B. H. Kent Total chemical synthesis of enzymatically active human type II secretory phospholipase A2 PNAS, July 22, 1997; 94(15): 7845 - 7850. [Abstract] [Full Text] [PDF]

				M. Murakami, Y. Nakatani, and I. Kudo Type II Secretory Phospholipase A2 Associated with Cell Surfaces via C-terminal Heparin-binding Lysine Residues Augments Stimulus-initiated Delayed Prostaglandin Generation J. Biol. Chem., November 22, 1996; 271(47): 30041 - 30051. [Abstract] [Full Text] [PDF]